Literature DB >> 21371021

Adults with a history of possible Dravet syndrome: an illustration of the importance of analysis of the SCN1A gene.

Nienke E Verbeek1, Marjan van Kempen, W Boudewijn Gunning, Willy O Renier, Birgit Westland, Dick Lindhout, Eva H Brilstra.   

Abstract

Most patients with Dravet syndrome have de novo mutations in the neuronal voltage-gated sodium channel type 1 (SCN1A) gene. We report on two unrelated fathers with severe childhood epilepsy compatible with a possible diagnosis of Dravet syndrome, who both have a child with Dravet syndrome. Analysis of the SCN1A gene revealed a pathogenic mutation in both children. One father exhibited somatic mosaicism for the mutation detected in his son. A relatively favorable cognitive outcome in patients with Dravet syndrome patients may be explained by somatic mosaicism for the SCN1A mutation in brain tissue. A mild form of Dravet syndrome in adult patients is associated with a high recurrence risk and possibly a more severe epilepsy phenotype in their offspring. Wiley Periodicals, Inc.
© 2011 International League Against Epilepsy.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21371021     DOI: 10.1111/j.1528-1167.2011.02982.x

Source DB:  PubMed          Journal:  Epilepsia        ISSN: 0013-9580            Impact factor:   5.864


  7 in total

1.  Quality improvement in neurology: Epilepsy Update Quality Measurement Set.

Authors:  Nathan B Fountain; Paul C Van Ness; Amy Bennett; John Absher; Anup D Patel; Kevin N Sheth; David S Gloss; Diego A Morita; Mona Stecker
Journal:  Neurology       Date:  2015-04-07       Impact factor: 9.910

2.  Visual automated fluorescence electrophoresis provides simultaneous quality, quantity, and molecular weight spectra for genomic DNA from archived neonatal blood spots.

Authors:  Tara L Klassen; Janice Drabek; Torjbörn Tomson; Olafur Sveinsson; Ulrika von Döbeln; Jeffrey L Noebels; Alicia M Goldman
Journal:  J Mol Diagn       Date:  2013-03-19       Impact factor: 5.568

3.  Nav 1.1 dysfunction in genetic epilepsy with febrile seizures-plus or Dravet syndrome.

Authors:  Linda Volkers; Kristopher M Kahlig; Nienke E Verbeek; Joost H G Das; Marjan J A van Kempen; Hans Stroink; Paul Augustijn; Onno van Nieuwenhuizen; Dick Lindhout; Alfred L George; Bobby P C Koeleman; Martin B Rook
Journal:  Eur J Neurosci       Date:  2011-08-22       Impact factor: 3.386

4.  Gene Panel Testing in Epileptic Encephalopathies and Familial Epilepsies.

Authors:  Rikke S Møller; Line H G Larsen; Katrine M Johannesen; Inga Talvik; Tiina Talvik; Ulvi Vaher; Maria J Miranda; Muhammad Farooq; Jens E K Nielsen; Lene Lavard Svendsen; Ditte B Kjelgaard; Karen M Linnet; Qin Hao; Peter Uldall; Mimoza Frangu; Niels Tommerup; Shahid M Baig; Uzma Abdullah; Alfred P Born; Pia Gellert; Marina Nikanorova; Kern Olofsson; Birgit Jepsen; Dragan Marjanovic; Lana I K Al-Zehhawi; Sofia J Peñalva; Bente Krag-Olsen; Klaus Brusgaard; Helle Hjalgrim; Guido Rubboli; Deb K Pal; Hans A Dahl
Journal:  Mol Syndromol       Date:  2016-08-20

5.  Antiepileptic Stiripentol May Influence Bones.

Authors:  Agnieszka Matuszewska; Beata Nowak; Anna Nikodem; Anna Merwid-Ląd; Benita Wiatrak; Tomasz Tomkalski; Diana Jędrzejuk; Ewa Szeląg; Tomasz Sozański; Maciej Danielewski; Paulina Jawień; Ireneusz Ceremuga; Marta Szandruk-Bender; Marek Bolanowski; Jarosław Filipiak; Adam Szeląg
Journal:  Int J Mol Sci       Date:  2021-07-02       Impact factor: 5.923

6.  Prevalence of SCN1A-related dravet syndrome among children reported with seizures following vaccination: a population-based ten-year cohort study.

Authors:  Nienke E Verbeek; Nicoline A T van der Maas; Floor E Jansen; Marjan J A van Kempen; Dick Lindhout; Eva H Brilstra
Journal:  PLoS One       Date:  2013-06-06       Impact factor: 3.240

7.  Comparative analytical utility of DNA derived from alternative human specimens for molecular autopsy and diagnostics.

Authors:  Tara L Klassen; Eva-Lotta von Rüden; Janice Drabek; Jeffrey L Noebels; Alica M Goldman
Journal:  J Mol Diagn       Date:  2012-07-13       Impact factor: 5.568

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.